Concepedia

Luis-Alexander Rodriguez

LR

8

Publications

329

Citations

8

H-Index

1988

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (Belgium)

Takeda (United States)

Eli Lilly (United States)

Pfizer (United States)

Luis-Alexander Rodriguez is an author at GlaxoSmithKline (United States) specializing in medicine, vaccine development, and vaccine safety.

ORCID

Top concepts

Publications per year

1988–2022

8

Publications

8

Prognostic implications of the proliferative potential of low-grade astrocytomas

Luis-Alexander Rodriguez, K G Cho, C Brown Wilson et al. · Journal of neurosurgery · 1988 · 153 citations

Nonclinical safety assessment of repeated administration and biodistribution of a novel rabies self-amplifying mRNA vaccine in rats

Alan H. Stokes, Johanne Pion, Ornella Binazon et al. · Regulatory Toxicology and Pharmacology · 2020 · 70 citations

, , +4

Treatment of Recurrent Brain Stem Gliomas and Other Central Nervous System Tumors with 5-Fluorouracil, CCNU, Hydroxyurea, and 6-Mercaptopurine

Luis-Alexander Rodriguez, Michael D. Prados, Dorcas Fulton et al. · Neurosurgery · 1988 · 34 citations

An In Vivo Platform for Tumor Biomarker Assessment

Elliot L. Servais, Kei Suzuki, Christos Colovos et al. · PLoS ONE · 2011 · 22 citations · Full text

Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy

Michael E. Dunn, Thomas G. Manfredi, Kevin Agostinucci et al. · Toxicologic Pathology · 2016 · 15 citations

, , +26

Rows per page

1–5 of 8